Lymphotoxin targeted to salivary and lacrimal glands induces tertiary lymphoid organs and cervical lymphadenopathy and reduces tear production
Authors:
Open Access
- 3 February 2020
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 50 (3) , 418-425
Abstract
To investigate the role of lymphotoxin (LT) in Sjögren's syndrome (SS) and in mucosal associated lymphoid tissue (MALT)‐lymphoma, we made transgenic mice (Amy1‐LTαβ) that targeted LTα and LTβ to the salivary and lacrimal glands. Amy1‐LTαβ mice developed atrophic salivary and lacrimal glands that contained tertiary lymphoid organs (TLOs) and had reduced tear production. Amy1‐LTαβ mice developed cervical lymphadenopathy but not MALT‐lymphoma. TLO formation in the salivary and lacrimal glands of Amy1‐LTαβ was not sufficient to induce autoimmunity as measured by autoantibody titres.Keywords
Funding Information
- Leukaemia and Lymphoma Research (09018, 11001)
- National Institutes of Health (R01DK57331, R21HL098711)
This publication has 31 references indexed in Scilit:
- Inducible Tertiary Lymphoid Structures, Autoimmunity, and Exocrine Dysfunction in a Novel Model of Salivary Gland Inflammation in C57BL/6 MiceThe Journal of Immunology, 2012
- Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in miceProceedings of the National Academy of Sciences, 2012
- Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndromeArthritis Research & Therapy, 2011
- Blocking lymphotoxin signaling abrogates the development of ectopic lymphoid tissue within cardiac allografts and inhibits effector antibody responsesThe FASEB Journal, 2011
- A Role for Lymphotoxin in Primary Sjögren’s DiseaseThe Journal of Immunology, 2010
- A yeast‐based recombinogenic targeting toolset for transgenic analysis of human disease genesAnnals of the New York Academy of Sciences, 2010
- Tumor Necrosis Factor (TNF) and Lymphotoxin- (LTA) Polymorphisms and Risk of Non-Hodgkin Lymphoma in the InterLymph ConsortiumAmerican Journal of Epidemiology, 2010
- IL-14 alpha, the nexus for primary Sjögren's disease in mice and humansClinical Immunology, 2009
- Overexpression of Lymphotoxin in T Cells Induces Fulminant Thymic InvolutionThe American Journal of Pathology, 2008
- Abnormal Development of Peripheral Lymphoid Organs in Mice Deficient in LymphotoxinScience, 1994